Advanced Molecular Diagnostics, LLC – Trademark Portfolio
Entity Type: 16
Advanced Molecular Diagnostics, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include GENEID, GENEPLUS, NEUROSEQ, COLO GENE, and PREVENTEST. The owner is based in Monsey, NY.
160 Saddle River Rd.
Monsey, NY 10952
Showing of trademarks Trademarks
Trademark Classifications
Advanced Molecular Diagnostics, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Advanced Molecular Diagnostics, LLC have?
Advanced Molecular Diagnostics, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending, 2 abandoned, 1 cancelled.
What trademark classes does Advanced Molecular Diagnostics, LLC file in?
Advanced Molecular Diagnostics, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Advanced Molecular Diagnostics, LLC's most well-known trademarks?
Advanced Molecular Diagnostics, LLC's registered trademark portfolio includes well-known marks such as GENEID, GENEPLUS, NEUROSEQ, COLO GENE, and PREVENTEST. These are among 6 currently registered trademarks in the portfolio.
What is Advanced Molecular Diagnostics, LLC's trademark registration success rate?
Advanced Molecular Diagnostics, LLC has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.